Momenta Pharmaceuticals, Inc. (MNTA)

[biopearl]

Thanks Dew, mouton and Boing. So are we at a place where one might speculate that if MNTA wins the patent case in DC assuming the CAFC rules as they should, is the eventual assessment of treble damages a possibility? (this has been discussed priviously in the remote past on this board) If so it could be ironic that the total value to MNTA of the outcome of this mess might actually be in excess of what might have happened had there never been entry of Amphastar and the erosion of MNTAs market, not just from competitors Ampha and Teva but the oral NOACs (novel oral anticoagulants) currently used as front line therapy for DVT and Pulmonary embolus which would have certainly also eventually eroded the enox market. That would be justice indeed! Anyway, fun to speculate and thanks to all for answering my questions. Dew, have you added to your 27,000 shares? Regards, bp